A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

NCT07674654 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Migraine

Interventions

DRUG: Elismetrep
DRUG: Placebo

Sponsor

Kallyope Inc.